Healthcare Customization And Additive Manufacturing Will Forge A Resilient Future

Key Takeaways

• Growth in healthcare and dental solutions, plus expanded digital manufacturing, positions the company for higher-margin recurring revenues and global market leadership.
  
• Strategic cost cuts, R&D commercialization, and industry shifts to decentralized production are set to drive sustainable profitability and diversify revenue streams.
  
• Prolonged macro uncertainty, delayed customer spending, aggressive restructuring, and rising competition threaten both 3D Systems' growth potential and long-term earnings stability.

Catalysts

Provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania.

• Demand for 3D Systems' healthcare solutions, particularly MedTech (personalized implants, trauma, and bone cancer treatments) and Dental (NextDent dentures), is benefitting from growing healthcare customization needs and rapid expansion of digital dentistry. These areas are poised to drive recurring, higher-margin service and product revenues as regulatory approvals expand globally, supporting both top-line and margin growth.
  
• The company's end-to-end additive manufacturing model (process, parts, printers) positions it to benefit from the shift toward on-demand, decentralized production and supply chain resiliency in sectors like aerospace, defense, and industrials. As adoption of additive manufacturing for production parts (beyond prototyping) accelerates, this model is likely to increase revenues and deliver operating leverage over time.
  
• Aggressive cost reduction initiatives-including in-sourcing manufacturing, global footprint consolidation, and automation of back-office functions-are expected to reduce COGS and OpEx, significantly improving gross margins and positioning the company for sustainable profitability and positive cash flow by 2026.
  
• Strategic R&D prioritization is moving from heavy investment (20% of sales) to commercialization of a refreshed portfolio of metal, polymer, and regenerative technologies, which is expected to result in increased product launches, expand addressable markets, and yield a better return on R&D, supporting long-term revenue and profit growth.
  
• Secular trends towards sustainability, efficient resource use, and supply chain localization are increasing demand for 3D printing and additive manufacturing, directly aligning with 3D Systems' distributed manufacturing and energy-efficient platform strengths, which should support resilient, diversified revenue streams and medium-term margin expansion.

3D Systems Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming 3D Systems's revenue will grow by 2.3% annually over the next 3 years.
• Analysts are not forecasting that 3D Systems will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate 3D Systems's profit margin will increase from 16.1% to the average US Machinery industry of 10.3% in 3 years.
• If 3D Systems's profit margin were to converge on the industry average, you could expect earnings to reach $42.8 million (and earnings per share of $0.24) by about June 2029, down from $62.4 million today.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 21.9x on those 2029 earnings, up from 8.5x today. This future PE is lower than the current PE for the US Machinery industry at 27.2x.
• Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 9.18%, as per the Simply Wall St company report.

Risks

• 3D Systems is experiencing a significant and protracted decline in customer capital expenditures for new production capacity, primarily due to macroeconomic uncertainty and volatile global tariff environments, which have caused a 16% year-over-year revenue decline; this trend, if sustained, could result in continued revenue stagnation or contraction.
  
• The ongoing macro challenges and customer uncertainty around where to locate manufacturing assets have led to elongated sales cycles and delayed large-capex purchases, potentially muting 3D Systems' ability to convert its pipeline and recover top-line industrial growth in a timely manner, risking both near
• and long-term revenue targets.
  
• The company is undertaking aggressive restructuring, including headcount reduction, facility consolidation, and R&D spending cuts; while aimed at improving margins and cash flow, this could compromise 3D Systems' innovation engine and leave it less competitive versus rivals that maintain or increase R&D, negatively impacting long-term earnings potential.
  
• Competitive risk remains high, especially as 3D printing hardware for certain markets (like dental) becomes commoditized and new entrants or incumbents, perhaps with deeper resources or more innovation velocity, may erode 3D Systems' market share and pricing power, which would place pressure on both margins and future revenue growth.
  
• The company's business mix has increased dependency on service and healthcare revenues, but weak performance in key verticals such as Dental-hit by both end-customer weakness and large customer order volatility-exposes the firm to further earnings volatility should sector adoption rates or market growth disappoint, risking both net margins and predictable earnings streams.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of $4.0 for 3D Systems based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $5.0, and the most bearish reporting a price target of just $3.0.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $414.7 million, earnings will come to $42.8 million, and it would be trading on a PE ratio of 21.9x, assuming you use a discount rate of 9.2%.
• Given the current share price of $3.61, the analyst price target of $4.0 is 9.8% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.